Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to Venables and Levell.
Ferguson J, Eleftheriadou V, Nesnas J. Ferguson J, et al. Among authors: eleftheriadou v. J Invest Dermatol. 2024 Feb;144(2):415-416. doi: 10.1016/j.jid.2023.09.286. Epub 2023 Nov 15. J Invest Dermatol. 2024. PMID: 37977499 Free article. No abstract available.
British Association of Dermatologists guidelines for the management of people with vitiligo 2021.
Eleftheriadou V, Atkar R, Batchelor J, McDonald B, Novakovic L, Patel JV, Ravenscroft J, Rush E, Shah D, Shah R, Shaw L, Thompson AR, Hashme M, Exton LS, Mohd Mustapa MF, Manounah L; British Association of Dermatologists’ Clinical Standards Unit. Eleftheriadou V, et al. Br J Dermatol. 2022 Jan;186(1):18-29. doi: 10.1111/bjd.20596. Epub 2021 Sep 7. Br J Dermatol. 2022. PMID: 34160061 No abstract available.
Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial.
Leighton P, Chalmers JR, Batchelor JM, Rogers A, Akram P, Haines RH, Meakin GD, White J, Ravenscroft JC, Sach TH, Santer M, Whitton ME, Eleftheriadou V, Thomas KS. Leighton P, et al. Among authors: eleftheriadou v. Clin Exp Dermatol. 2022 Aug;47(8):1480-1489. doi: 10.1111/ced.15193. Epub 2022 May 30. Clin Exp Dermatol. 2022. PMID: 35340044 Free PMC article. Clinical Trial.
Skin is a window to one's inner world.
Eleftheriadou V, Thompson AR. Eleftheriadou V, et al. Br J Dermatol. 2023 Oct 25;189(5):501-502. doi: 10.1093/bjd/ljad300. Br J Dermatol. 2023. PMID: 37624845 No abstract available.
Getting evidence into practice: C3 will see it through.
Eleftheriadou V, Mohd Mustapa MF. Eleftheriadou V, et al. Br J Dermatol. 2023 Feb 22;188(3):311-312. doi: 10.1093/bjd/ljac062. Br J Dermatol. 2023. PMID: 36640124 No abstract available.
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
Thomas KS, Batchelor JM, Akram P, Chalmers JR, Haines RH, Meakin GD, Duley L, Ravenscroft JC, Rogers A, Sach TH, Santer M, Tan W, White J, Whitton ME, Williams HC, Cheung ST, Hamad H, Wright A, Ingram JR, Levell NJ, Goulding JMR, Makrygeorgou A, Bewley A, Ogboli M, Stainforth J, Ferguson A, Laguda B, Wahie S, Ellis R, Azad J, Rajasekaran A, Eleftheriadou V, Montgomery AA; UK Dermatology Clinical Trials Network’s HI-Light Vitiligo Trial Team. Thomas KS, et al. Among authors: eleftheriadou v. Br J Dermatol. 2021 May;184(5):828-839. doi: 10.1111/bjd.19592. Epub 2020 Dec 28. Br J Dermatol. 2021. PMID: 33006767 Clinical Trial.
59 results